BTG3 and rheumatoid arthritis: As shown in Figure 4EH, both the TNZ and MTX treated groups showed significant and substantial (p < 0.001) attenuation in the expression levels of serum anti-dsDNA, anti-CarP, anti-MCV, and ANA proteins, compared to the FCA-induced RA model.